InsidersTradesSigma
Total declarations
Companies
▲ Purchases (8 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
8
Disclosed sells
4
T+90 hit rate
0%
T+90 mean return
-39.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Berger Franklin M, Directeur Juridique. Officer active across 5 companies, notably Kezar Life Sciences, Inc.. Aggregated, 18 reports have been recorded. Breakdown: 8 buys · 4 sells. Total volume traded: €2.6m. Activity tracked since 21 September 2021. The latest transaction was disclosed on 20 June 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Berger Franklin M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
29,600 sharesCommon StockSEC:0001193125-26-279726:0
784,404 sharesCommon SharesSEC:0001104659-25-099655:0
29,600 shares0Common StockSEC:0000950170-25-089606:0
15,000 shares@ US$3.19233.7% of flowCommon StockSEC:0000950170-25-006489:0
Canonical exit: 15 Apr 2025 (T+90)
15,000 shares@ US$3.19233.7% of flowCommon StockSEC:0000950170-25-006589:0
Canonical exit: 15 Apr 2025 (T+90)
359,606 shares@ US$2.846176.2% of flowCommon StockSEC:0000950170-24-135930:0
33,150 shares0Common StockSEC:0000950170-24-074987:0
1,005,207 sharesCommon Stock, par value $0.001 per shareSEC:0001999371-24-000962:0
23,259 shares@ US$5.7324.6% of flowCommon SharesSEC:0000950170-23-065921:0
Canonical exit: 19 Feb 2024 (T+90)
60,000 shares@ US$5.3561.2% of flowCommon StockSEC:0000950170-23-064584:0
Canonical exit: 31 Jan 2024 (T+90)
25,000 shares@ US$3.0014.2% of flowCommon SharesSEC:0000899243-23-000914:0
45,000 shares@ US$7.8049.8% of flowCommon StockSEC:0001104659-22-121849:0
Canonical exit: 19 Feb 2023 (T+90)
25,500 shares@ US$5.150310.1% of flowCommon StockSEC:0000899243-22-035942:0
16,166 shares@ US$5.1566.3% of flowCommon StockSEC:0000899243-22-035942:1
42,881 shares@ US$5.8336.6% of flowCommon StockSEC:0000899243-22-035691:0
Canonical exit: 6 Feb 2023 (T+90)
15,000 shares@ US$15.9682.8% of flowCommon StockSEC:0001209191-22-020584:0
Canonical exit: 16 Jun 2022 (T+90)
3,786 shares@ US$14.307.3% of flowCommon StockSEC:0000899243-21-037351:0
Canonical exit: 20 Dec 2021 (T+90)
8,896 shares@ US$5.9117.2% of flowCommon StockSEC:0001209191-21-057418:0
18 of 18 declarations
About Berger Franklin M
BERGER FRANKLIN M is Directeur Juridique. He has 18 filings in total, and in the recent sampled filings, buys and sells span from 2021-09-23 to 2026-06-23, with buy volume of EUR 1369032 and sell volume of EUR 1249773, and the most frequent transaction nature being Acquisition. He is also a director of Atea Pharmaceuticals, Inc., ESSA Pharma Inc., Rain Therapeutics Inc., Kezar Life Sciences, Inc. and Rain Oncology Inc.
